POST enters its August 7 earnings call with short sellers pulling back, borrow conditions easy, and a cluster of analysts who still believe in the story but are marking down their targets heading into the print.
Short interest has drifted steadily lower over the past month, falling roughly 6% to just under 12% of the free float — still an elevated absolute level, but the direction favors bulls. The borrow market is not under pressure: availability runs at around 326%, meaning shares to lend are plentiful relative to the amount already shorted, and cost-to-borrow is a negligible 0.5%. That combination — high SI by consumer-staples standards but falling, with easy borrow — tells a story of shorts who entered the trade earlier and are gradually exiting, not fresh sellers pressing a new thesis.
Options positioning has actually shifted less bearishly into the print than recent history suggests. The put/call ratio of 4.5 looks eye-catching in isolation, but it is running nearly two standard deviations below its 20-day average of 4.9 — closer to the lowest defensive posturing in months. For a stock with a PCR that has sat persistently above 5 since late June, a dip to 4.5 represents relative calm. The ORTEX short score has also eased slightly, from around 67.9 a week ago to 66.6 now, consistent with the same modest softening in bearish positioning.
The debate on POST heading into today centers on whether the company's growth levers — particularly the 8th Avenue acquisition — can offset the category-level volume headwinds that have weighed on estimates all year. Bulls point to roughly $625 million in cash, a deal priced at approximately 7x EBITDA, and expected synergies that have not yet been fully reflected in consensus numbers; forward EPS momentum ranks in the 86th percentile of the universe on a 12-month basis, a meaningful signal. Bears counter with sustained volume pressure: Gravy Train pricing elasticity, the exit from private label co-manufacturing, and Nutrish weakness each knocked multiple percentage points off sales growth, and estimates were revised sharply lower through the first half of the year. The consensus has been drifting in one direction only — multiple bellwether firms including Barclays, JPMorgan, and Wells Fargo all trimmed targets in July while keeping positive ratings, a pattern that signals ongoing confidence in the long-run story but a more cautious read on near-term delivery. The mean price target of roughly $116 implies meaningful upside from $90, but that gap has been narrowing for months.
The last comparable earnings event, in May, produced a mild 2.4% one-day drop and a further slide over the following week — a reminder that even a credible bull case has not historically been enough to drive a sharp re-rating. This print will test whether the 8th Avenue deal is already showing up in margins, or whether the volume drags across pet food brands are deeper than the revised estimates have captured.
See the live data behind this article on ORTEX.
Open POST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
